Efficacy and Safety of Recombinant Human Insulin Patch ZJSRM2021

NCT05089942 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

16

Enrollment

OTHER

Sponsor class

Conditions

type1diabetes
Type2 Diabetes

Interventions

DRUG: Recombinant Human Insulin Patch ZJSRM2021
DRUG: Placebo

Sponsor

Zhejiang Provincial People's Hospital